Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M S Lau

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Oncogene|August 19, 2007
HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 functionL M S Lau, J K Nugent, X Zhao, et al.
Oncogene|April 14, 2009
Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastomaL M S Lau, J K Wolter, J T M L Lau, et al.
Cancer Reports (Hoboken, N.J.)|April 25, 2024
High throughput screening aids clinical decision-making in refractory acute myeloid leukaemiaS J Jessop, N Fuentos-Bolanos, C Mayoh, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Oncogene|August 19, 2007
HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 functionL M S Lau, J K Nugent, X Zhao, et al.
Oncogene|April 14, 2009
Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastomaL M S Lau, J K Wolter, J T M L Lau, et al.
Cancer Reports (Hoboken, N.J.)|April 25, 2024
High throughput screening aids clinical decision-making in refractory acute myeloid leukaemiaS J Jessop, N Fuentos-Bolanos, C Mayoh, et al.
Pageof 1